UAE Takes Lead in Approving Innovative Medications

 

UAE

UAE is usually one of the top three countries for quickly approving innovative medicines and treatments, including but not limited to genetic treatments for spinal muscular atrophy (SMAs) and vision loss. Furthermore, MoHAP also approved innovative biological drugs for Alzheimer's and diabetes that are only available in the USA and the UAE.

HE Dr. Amin Hussein Al Amiri, Assistant Undersecretary for the Health Regulation Sector, said that the ministry is committed to expediting medication registration procedures to deliver effective treatments to patients and support the pharmaceutical sector.

Al Amiri stressed that MoHAP is striving to enhance the drug regulation and control process and is therefore sparing no effort to bolster local and foreign pharmaceutical businesses operating in the UAE, adding that the ministry's success in this field will only strengthen the UAE's position as a regional leader in healthcare and medicine. 

Result  of this  UAE has topped the Middle East and Africa (MEA) in terms of the number of approved medications containing novel active substances and the speed at which drug regulatory dossiers are evaluated and approved, according to an announcement made by the Ministry of Health and Prevention (MoHAP).

Over all  This accomplishment was made possible by the ministry shortening the time needed to assess new medication dossiers, enabling it to approve 187 new medicines containing active ingredients throughout the study period.

Comments

Popular posts from this blog

The UAE's Positive Role in Facilitating Prisoner Exchange: A Peace and Humanitarian Aid Beacon

UAE Facilitates Prominent Prisioner Swap Between Russia and Ukraine

Masdar's Practical Strategy for Indonesia's Renewable Growth